News

Rare Childhood Leukemia Reveals Surprising Genetic Secrets

Rare Childhood Leukemia Reveals Surprising Genetic Secrets

October 12, 2015

A coalition of leukemia researchers led by scientists from UC San Francisco has discovered surprising genetic diversity in juvenile myelomonocytic leukemia (JMML), a rare but aggressive childhood blood cancer.

Online Advertising Can Deliver Targeted Cancer Prevention Messages, UCSF Study Finds

Online Advertising Can Deliver Targeted Cancer Prevention Messages, UCSF Study Finds

October 8, 2015

Online advertising based on Google search terms is a potentially effective way to deliver targeted cancer prevention education, according to a study led by Eleni Linos, MD, DrPH, an assistant professor of dermatology at UC San Francisco.

image

NIH Awards ‘High-Risk, High-Reward’ Grants to Seven UCSF Researchers

October 6, 2015

The National Institutes of Health (NIH) has awarded seven grants to UC San Francisco scientists to pursue innovative approaches to major contemporary challenges in biomedical research.

Five Things Women Should Know About Breast Cancer

Five Things Women Should Know About Breast Cancer

October 1, 2015

Breast cancer is the most common kind of cancer among American women, except for skin cancer, and the second leading cause of cancer death in women, exceeded only by lung cancer. But emerging knowledge offers reason for optimism. Here are five things women should know about breast cancer, according to Dr. Laura Esserman.

UCSF Researchers Awarded Breast Cancer Research Funding from Susan G. Komen

UCSF Researchers Awarded Breast Cancer Research Funding from Susan G. Komen

September 28, 2015

Three UCSF researchers were awarded a total of $560,000 to support projects in breast cancer research. These grants are among those made to 124 researchers in 25 states and 15 countries, with about half of the grants targeted to early-career investigators.

‘Remote Control’ of Immune Cells Opens Door to Safer, More Precise Cancer Therapies

‘Remote Control’ of Immune Cells Opens Door to Safer, More Precise Cancer Therapies

September 24, 2015

UC San Francisco researchers have engineered a molecular “on switch” that allows tight control over the actions of T cells, immune system cells that have shown great potential as therapies for cancer.

image

Metastatic Breast Cancer Cells Turn On Stem Cell Genes

September 23, 2015

Metastases cause the vast majority of cancer deaths, but their tiny seeds are so difficult to track that few researchers have managed to study them. Now, scientists from UC San Francisco describe capturing and studying individual metastatic cells from human breast cancer tumors implanted into mice as the cells escaped into the blood stream and began to form tumors elsewhere in the body.

Building Human Breast Tissue, Cell by Cell

Building Human Breast Tissue, Cell by Cell

September 23, 2015

The next frontier in developing therapies for cancer and other diseases could come through studying organ development or tumor growth in living humans. Problem is, there’s no ethical way of doing that using current technology. Zev Gartner, PhD, has focused on the next best thing: His lab is building fully functioning 3-D human tissue, cell by cell.

Around The World, Those Treated for Addiction Far More Likely to Smoke

Around The World, Those Treated for Addiction Far More Likely to Smoke

September 22, 2015

People in addiction treatment programs around the world use tobacco at two to three times the rate of people who are not being treated for addiction, according to a review of research studies from 20 countries other than the United States. The review, led by Joseph R. Guydish, PhD, a UC San Francisco professor of medicine and health policy, was published on Tuesday, Sept. 22 in the journal Addiction.

image

Antibody Network Partners With Celgene for Cancer Therapies

September 15, 2015

A new collaboration between Celgene Corp. and the Recombinant Antibody Network (RAN), a consortium comprising research groups from UC San Francisco (UCSF), the University of Chicago and the University of Toronto, will support the development of next-generation, antibody-based cancer therapies.